Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3166 AL 3180

What works and what does not work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials

Bullain S, Doody R.

J Neurochem. 2020 Sep;155(2):120-136. doi: 10.1111/jnc.15023. Epub 2020 May 9.

Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

Manduca JD, Thériault RK, Perreault ML.

Pharmacol Res. 2020 Jul;157:104819. doi: 10.1016/j.phrs.2020.104819. Epub 2020 Apr 17.

Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review

Pei H, Ma L, Cao Y, Wang F, Li Z, Liu N, Liu M, Wei Y, Li H.

Am J Chin Med. 2020;48(3):487-511. doi: 10.1142/S0192415X20500251. Epub 2020 Apr 24.

An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Chan Kwong A, Cassé-Perrot C, Costes-Salon MC, Jouve E, Lanteaume L, Audebert C, Rouby F, Lefebvre MN, Ranjeva JP, Beck A, Deplanque D, Ponchel A, Vervueren C, Truillet R, Babilon C, Auffret A, Richardson JC, Payoux P, Bartrés-Faz D, Blin O, Bordet R, Micallef J; Pharmacog Consortium.

J Clin Psychopharmacol. 2020 May/Jun;40(3):222-230. doi: 10.1097/JCP.0000000000001199.

Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs

Avgerinos KI, Vrysis C, Chaitidis N, Kolotsiou K, Myserlis PG, Kapogiannis D.

Neurol Sci. 2020 Oct;41(10):2747-2754. doi: 10.1007/s10072-020-04427-0. Epub 2020 May 23.

Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies

Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):158-164. doi: 10.14283/jpad.2020.19.

Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting

Sabbagh MN, Boada M, Borson S, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):171-178. doi: 10.14283/jpad.2020.22.

Treatment Development for Alzheimer's Disease: How Are We Doing?

Lyketsos CG.

Adv Exp Med Biol. 2020;1195:19. doi: 10.1007/978-3-030-32633-3_3.

Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease

Uddin MS, Rahman MA, Kabir MT, Behl T, Mathew B, Perveen A, Barreto GE, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

IUBMB Life. 2020 Sep;72(9):1843-1855. doi: 10.1002/iub.2324. Epub 2020 May 30.

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.

Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.

Placebo effect in subjects with cognitive impairment

Ito K, Romero K.

Int Rev Neurobiol. 2020;153:213-230. doi: 10.1016/bs.irn.2020.03.032. Epub 2020 Jun 9.

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.

JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK.

Life Sci. 2020 Sep 15;257:118020. doi: 10.1016/j.lfs.2020.118020. Epub 2020 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias